Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Dynamic microsimulation models for health outcomes: a review.

Rutter CM, Zaslavsky AM, Feuer EJ.

Med Decis Making. 2011 Jan-Feb;31(1):10-8. doi: 10.1177/0272989X10369005. Epub 2010 May 18. Review.

2.

Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.

Chilcott J, Tappenden P, Rawdin A, Johnson M, Kaltenthaler E, Paisley S, Papaioannou D, Shippam A.

Health Technol Assess. 2010 May;14(25):iii-iv, ix-xii, 1-107. doi: 10.3310/hta14250. Review.

3.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

4.

Generalisability in economic evaluation studies in healthcare: a review and case studies.

Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A.

Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. Review.

5.

Matching study designs to disability-related comparative effectiveness research questions.

Ballou J, Rich E, Kehn M.

J Comp Eff Res. 2013 Jan;2(1):59-68. doi: 10.2217/cer.12.75. Review.

PMID:
24236522
6.

The use of surrogate outcomes in model-based cost-effectiveness analyses: a survey of UK Health Technology Assessment reports.

Taylor RS, Elston J.

Health Technol Assess. 2009 Jan;13(8):iii, ix-xi, 1-50. doi: 10.3310/hta13080. Review.

7.

Risk management frameworks for human health and environmental risks.

Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S.

J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. Review.

PMID:
14698953
8.

Selecting a dynamic simulation modeling method for health care delivery research-part 2: report of the ISPOR Dynamic Simulation Modeling Emerging Good Practices Task Force.

Marshall DA, Burgos-Liz L, IJzerman MJ, Crown W, Padula WV, Wong PK, Pasupathy KS, Higashi MK, Osgood ND; ISPOR Emerging Good Practices Task Force.

Value Health. 2015 Mar;18(2):147-60. doi: 10.1016/j.jval.2015.01.006. Review.

9.

Computer disease simulation models: integrating evidence for health policy.

Rutter CM, Knudsen AB, Pandharipande PV.

Acad Radiol. 2011 Sep;18(9):1077-86. doi: 10.1016/j.acra.2011.02.004. Epub 2011 Mar 23. Review.

10.

Recent developments in decision-analytic modelling for economic evaluation.

Weinstein MC.

Pharmacoeconomics. 2006;24(11):1043-53. Review.

PMID:
17067190
11.

Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.

Flynn MA, McNeil DA, Maloff B, Mutasingwa D, Wu M, Ford C, Tough SC.

Obes Rev. 2006 Feb;7 Suppl 1:7-66. Review.

PMID:
16371076
12.

Validation of population-based disease simulation models: a review of concepts and methods.

Kopec JA, Fin├Ęs P, Manuel DG, Buckeridge DL, Flanagan WM, Oderkirk J, Abrahamowicz M, Harper S, Sharif B, Okhmatovskaia A, Sayre EC, Rahman MM, Wolfson MC.

BMC Public Health. 2010 Nov 18;10:710. doi: 10.1186/1471-2458-10-710. Review.

13.

Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology.

Basch E, Abernethy AP, Mullins CD, Reeve BB, Smith ML, Coons SJ, Sloan J, Wenzel K, Chauhan C, Eppard W, Frank ES, Lipscomb J, Raymond SA, Spencer M, Tunis S.

J Clin Oncol. 2012 Dec 1;30(34):4249-55. doi: 10.1200/JCO.2012.42.5967. Epub 2012 Oct 15. Review.

PMID:
23071244
14.

The use of claims databases for outcomes research: rationale, challenges, and strategies.

Motheral BR, Fairman KA.

Clin Ther. 1997 Mar-Apr;19(2):346-66. Review.

PMID:
9152572
15.

Simulation modeling of outcomes and cost effectiveness.

Ramsey SD, McIntosh M, Etzioni R, Urban N.

Hematol Oncol Clin North Am. 2000 Aug;14(4):925-38. Review.

PMID:
10949781
16.

Comparative effectiveness research in oncology methodology: observational data.

Hershman DL, Wright JD.

J Clin Oncol. 2012 Dec 1;30(34):4215-22. doi: 10.1200/JCO.2012.41.6701. Epub 2012 Oct 15. Review.

PMID:
23071228
17.

Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.

Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N.

Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. Review.

18.

The need for microsimulation to evaluate osteoporosis interventions.

Vanness DJ, Tosteson AN, Gabriel SE, Melton LJ 3rd.

Osteoporos Int. 2005 Apr;16(4):353-8. Epub 2005 Jan 11. Review.

PMID:
15645319
19.

The significance of quality of life in health care.

Kaplan RM.

Qual Life Res. 2003;12 Suppl 1:3-16. Review.

PMID:
12803306
20.

What is outcomes research and what can it tell us?

Slater CH.

Eval Health Prof. 1997 Sep;20(3):243-64. Review.

PMID:
10183323
Items per page

Supplemental Content

Write to the Help Desk